Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

24

Summary: She has become one of the country’s leading advocates on patient-centered drug development and clinical trial design 

 

The Alpha-1 Project (TAP) announces the appointment of Karen Erickson as Chief Operating Officer, a new position within TAP. The appointment is effective November 1, 2018.

 

Ms. Erickson leaves her position as Associate Executive Director for Community Engagement at the Alpha-1 Foundation, where she has served the Alpha-1 community for the past five years. 

 

Prior to joining the Foundation, she was employed at Amgen in drug product process development and clinical operations. She has a global perspective on clinical operations and performance management and held an expat position in portfolio and technology transfer at Trinity Biotech, Bray, Co. Wicklow, Ireland. 

 

She was co-founder and Chair of Ability Bettered through Leadership and Education (ABLE), an affinity group commissioned to improve the quality of life of Amgen employees and community members who were differently challenged by disease or conditions. 

Ms. Erickson is an active member of the Alpha-1 Antitrypsin Deficiency (Alpha-1) and rare disease communities. She has become one of the country’s leading advocates on patient-centered drug development and clinical trial design representing the Foundation on a variety of committees including the American Thoracic Society Public Advisory Roundtable, Clinical Trial Transformation Initiative, National Center for Advancing Translational Sciences (NCATS), and the newly formed U.S. Food and Drug Administration (FDA) Patient Engagement Collaborative. She is an Alpha-1 patient and received a bilateral lung transplant in March of 2013.  

 

“We are delighted to have Karen join our team where her professional and personal experiences will help TAP and its parent, the Alpha-1 Foundation fulfill its mission to find cures and therapies for lung and liver diseases caused by Alpha-1”, said Jean-Marc Quach, President and CEO of TAP.